Drugs interacting with G protein α subunits: Selectivity and perspectives

Fundamental and Clinical Pharmacology

Volumn 12, Issue 2, 1998, Pages 121-132

  Chahdi, A ^a   Daeffler, L ^a   Gies, J P ^a   Landry, Y ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

G protein antagonists; G proteins; Mastoparan and related peptides; Receptor independent G protein activation

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MASTOPARAN; NEUROPEPTIDE; PEPTIDE HORMONE; POLYAMINE; PROTEIN SUBUNIT; SUBSTANCE P DERIVATIVE; SURAMIN;

BINDING SITE; DRUG RECEPTOR BINDING; DRUG TARGETING; DRUG TOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031967878     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00932.x     Document Type: Review

References (150)

1. Akoun GM, Gauthier-Rahman S, Milleron BJ, Perrot JY, Mayaud CM. Amiodarone-induced hypersensitivity pneumonitis: evidence of an immunological cell-mediated mechanism. Chest 1984 ; 85 : 133-5
2. Akoun GM, Gauthier-Rahman S, Milleron BJ, Liote HA, Mayaud CM. Leukocyte migartion inhibition in amiodarone-associated pneumonitis. Chest 1988 ; 94 : 1050-3
3. Aridor M, Traub L, Sagi-Eisenberg R. Exocytosis in mast cells by basic secretagogues, evidence for direct activation of GTP-binding proteins. J Cell Biol 1990 ; 111 : 909-17
4. Argiolas A, Pisano JJ. Facilitation of phospholipase A2 activity by mastoparan, new class of mast cell degranulating peptides from wasp venom. J Biol Chem 1983 ; 258 : 13697-702
5. Bar-Shavit Z, Goldman R, Stabinsky Y, Gottelib P, Blumberg S. Enhancement of phagocytosis. A newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980 ; 94 : 14-19
6. Berchtold H, Reshetnikova L, Reiser C, Schirmer NK, Sprinzl M, Hilgenfeld R. Crystal structure of active elongation factor Tu reveals major domain rearrangements. Nature 1993 ; 365 : 126-32
7. Beindl W, Mitterauer T, Hohenegger M, Ijzerman AP, Nanoff C, Freissmuth M. Inhibition of receptor/G protein coupling by suramin analogues. Mol Pharmacol 1996 ; 50 : 415-23
8. Berman DM, Kozasa T, Gilman AG. The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem 1996 ; 271 : 27209-12
9. Berstein G, Blank JL, Smrcka AV, Higashijima T, Sternweis PC, Exton JH, Ross EM. Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified ml muscarinic receptor, Gq/11, and phospholipase C b1. J Biol Chem 1992 ; 267 : 8080-8
10. Bertin B, Freissmuth M, Breyer R, Schütz W, Strosberg AD, Marullo S. Functional expression of the human serotonine 5-HT1A receptor in Escherichia coli. J Biol Chem 1992 ; 267 : 8200-6
11. Bidwai AP, Morjana NA, Scarborough GA. Purification and characterization of casein kinase II (CKII) from delta cka1 delta cka2 Saccharomyces cerevisiae rescued by Drosophila CKII subunits. J Biol Chem 1989 ; 264 : 11790-5
12. Bourne HR, Sanders DA, McCormick F. The GTPase super-family: a conserved switch for diverse cell functions. Nature 1990 ; 348 : 125-32
13. Bourne HR, Sanders DA, McCormick F. The GTPase super-family: conserved strucrure and molecular mechanism. Nature 1991 ; 349 : 117-27
14. Bowlin TL, Hoepper BJ, Rosenberger AL, Davis GF, Sunkara PS. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice. Cancer Res 1990 ; 50 : 4510-14
15. Bueb JL, Mousli M, Bronner C, Rouot B, Landry Y. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells. Mol Pharmacol 1990 ; 38 : 816
16. Bueb JL, Mousli M, Landry Y, Regoli D. Structure-activity studies of bradykinin analogs on rat mast cell histamine release. Peptides 1992 ; 14 : 685-9
17. Bueb JL, Mousli M, DaSilva A, Landry Y. Natural polyamines stimulate G proteins. Biochem J 1992 ; 282 : 545-50
18. Butler SJ, Kelly ECH, Mckenzie FR, Guild SB, Wakelam MJO, Milligan G. Differential effects of suramin on the coupling of receptors to individual species of pertussis toxin-sensitive G proteins. Biochem J 1988 ; 251 : 201-5
19. 2+ current via Go in rat sympathetic neurons. J Physiol 1994 ; 477 : 415-22
20. Chao J, Seiler N, Renault J, Kashiwagi K, Masuko T, Igarashi K, Williams K. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonist. Mol Pharmacol 1997 ; 51 : 861-71
21. Chatterjee TK, Eapen AK, Fischer RA. A truncated form of RGS3 negatively regulates G protein-coupled receptor stimulation of adenylyl cyclase and phosphoinositide phospholipase C. J Biol Chem 1997 ; 272 : 15481-7
22. Chen CK, Wieland T, Simon MI. RGS-r, a retinal specific RGS protein, binds an intermediate conformation of transducin and enhances recycling. Proc Natl Acad Sci USA 1996 ; 93 : 12885-9
23. Cheung AH, Sigal IS, Dixon RAF, Strader CD. Agonist-promoted sequestration of the β2-adrenergic receptor requires regions involved in functional coupling with GS. Mol Pharmacol 1989 ; 35 : 132-8
24. Cheung AH, Huang RC, Graziano MP, Strader CD. Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the β-adrenergic receptor. FEBS Lett 1991 ; 279 : 277-80
25. Conklin BR, Bourne HR. Structural elements of Gα-subunits that interact with G βγ-subunits, receptors and effectors. Cell 1993 ; 73 : 631-41
26. Costa T, Ogino Y, Munson PJ, Onaran O, Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonisme and of receptor activity in the absence of ligand. Mol Pharamcol 1992 ; 41 : 549-60
27. Covino BG. Toxicity and cystemic effects of local anesthetic agents. In: Experimental Pharmacology. Berlin: Springer; 1987.p 187-212
28. Devillier P, Renoux M, Drapeau G, Regoli D. Histamine release from rat peritoneal mast cells by kinin antagonists. Eur J Pharmacol 1988 ; 149 : 137-40
29. Devillier P, Drapeau G, Renoux M, Regoli D. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin, and related peptides. Eur J Pharmacol 1989 ; 168 : 53-60
30. Dohlman HG, Song J, Ma D, Courchesne WE, Thorner J. Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpal (the G protein α subunit). Mol Cell Biol 1996 ; 16 : 5194-209
31. Druey KM, Blumer KJ, Kang VH, Kehrl JH. Inhibition of G protein-mediated MAP kinase activation by a new mammalian gene family. Nature 1996 ; 379 : 742-6
32. Echt DS, Liebson PR, Mitchell LB, Baker A, Richardson DW, the CAST investigators. Mortality and morbidity in patients receiving encaininde, flecainide, or placebo: the cardiac arrhythmia suppression trial. N Engl J Med 1991 ; 324 : 781-8
33. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a- and C5a-induced mediator release from dissiciated human skin mast cells. J Invest Dermatol 1994 ; 102 : 803-6
34. Emadi-Khiav B, Mousli M, Bronner C, Landry Y. Human and rat cutaneous mast cells : involvement of G protein in the response to peptidergic stimuli. Eur J Pharmacol 1995 ; 272 : 97-102
35. Fischer T, Bronner C, Landry Y, Mousli M. The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway. Biochim Biophys Acta 1993 ; 1176 : 305-12
36. Foreman JC, Jordan CC, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol 1983 ; 335 : 449-65
37. Foreman JC. Peptides and neurogenic inflammation. Br Med Bull 1987; 43 : 386-400
38. Foreman JC. The pharmacology of neuropeptides in mast cells and skin: its implication for the physiology of blood flow in normal and diseased human skin. Asia Pac J Pharmacol 1991 ; 6 : S1-9
39. Freissmuth M, Schütz W, Linder ME. Interaction of the bovine brain A1-adenosine receptor with recombinant G protein a subunits. J Biol Chem 1991 ; 266 : 17778-83
40. Freissmuth M, Boehm S, Beindl W, Nickel P, Ijzerman AP, Hohenegger M, Nanoff C. Suramin analogues as subtype-selective G protein inhibitors. Mol Pharmacol 1996 ; 49 : 602-11
41. Fukuoka Y, Hugli TE. Anaphylatoxin binding and degranulation by rat peritoneal mast cells. J Immunol 1990 ; 145 : 1851-7
42. Gill J, Heel RC, Fitton A. Amiodarone: an overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 1992 ; 43 : 69-110
43. Gilman AG. G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 1987 ; 56 : 615-49
44. Gusovsky F, Soergel DG, Daly JW. Effects of mastoparan and related peptides on phosphoinositide breakdown in HL-60 cells and cell-free preperation. Eur J Pharmacol 1991 ; 206 : 309-14
45. Hagelüken A, Grünbaum L, Nürnberg B, Harhammer R, Seifert R. Lipophilic β-adrenoceptor antagonists and local anesthetics are effective direct activators of G proteins. Biochem Pharmacol 1994 ; 47 : 1789-95
46. Hagelüken A, Nürnberg B, Harhammer R, Grünbaum L, Seifert R. The class III antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G proteins. Mol Pharmacol 1995 ; 47: 234-40
47. Hartung HP, Wolters K, Toyka KV. Substance P binding properties and studies on cellular response in guinea-pig macrophages. J Immunol 1986 ; 136 : 3856-61
48. Helme RD, Eglezos A, Hosking CS. Substance P induces chemotaxis of neutrophils in normal and capsaicin-treated rats. Immunol Cell Biol 1987 ; 65 : 267-71
49. Hepler JR, Oilman AG. G proteins. Trends Biochem Sci 1992 ; 17 : 383-7
50. Higashjima T, Uzu S, Nakajima T, Ross EM. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem 1988 ; 263 : 6491-4
51. Higashijima T, Bumier J, Ross EM. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and Hydrophobic amines. J Biol Chem 1990 ; 265 : 14176-86
52. Higashijima T, Ross EM. Mapping of the mastoparan-binding site on G proteins. J Biol Chem 1991 ; 266 : 12655-61
53. Hirai Y, Yasuhara T, Yoshida H, Fujino M, Kitada C. A new mast cell degranulating peptide "mastoparan" in the venom of Vaspula lewisii. Chem Pharmacol Bull 1979 ; 27 : 1942-4
54. 2+-ATPase of sarcoplasmic reticulum via the catalytic adenosine-nucleotide-binding site. Eur J Biochem 1992 ; 205 : 173-9
55. Hohenegger M, Nanoff C, Ahron H, Freissmuth M. Structural and functional characterization of the interaction between 2′:3′-dialdehyde guanine nucleotide analogues and the stimulatory G protein a subunits. J Biol Chem 1994 ; 269 : 32008-15
56. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988 ; 24 : 739-68
57. Huang RC, Dehaven RN, Cheung AH, Diehl RE, Strader CD. Identification of allosteric antagonists of receptor-G protein interactions. Mol Pharmacol 1990 ; 37 : 304-10
58. Huang C, Hepler JR, Gilman AG, Mumby SM. Attenuation of Gi- and Gq-mediated signalling by expression of RGS4 or GAIP in mammalian cells. Pro Natl Acad Sci USA 1997 ; 94 : 6159-63
59. Hugli TE. Structure and function of C3a anaphylatoxin. Curr Top Microbiol Immunol 1989 ; 135 : 151-63
60. Hunt TW, Fields TA, Casey PJ, Peralta EJ. RGS 10 is a selective activator of Gαi GTPase activity. Nature 1996 ; 383 : 175-7
61. Hurley JB, Simon MI, Teplow D, Robishaw JD, Gilman AG. Homologies between signal transducing G proteins and ras gene product. Science 1984 ; 226 : 860-2
62. Jasani B, Kreil G, Mackler BF, Stanworth DR. Further studies on the structural requirements for plypeptide-mediated histamine release from rat mast cells. Biochem J 1979 ; 181 : 623-32
63. Jurnak F. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene protein. Science 1985 ; 230 : 32-6
64. Kikkawa S, Takahashi K, Shimada N, Ui M, Katada T. Activation of nucleoside diphosphate kinase by mastoparan, a peptide isolated from wasp venom. FEBS Lett 1992 ; 305 : 237-40
65. Kjartansson J, Dalsgaard CJ. Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat. Eur J Pharmacol 1987 ; 142 : 355-8
66. Koelle MR. A new family of G-protein regulators, the RGS proteins. Curr Opin Cell Biol 1997 ; 9 : 143-7
67. König B, Arendt A, McDowell JH, Kahlert M, Hofman KP. Three cytoplasmic loops of rhodopsin interact with transducin. Proc Natl Acad Sci USA 1989 ; 86 : 6878-82
68. Kurose H, Regan J, Caron MG, Lefkowitz RJ. Functional interactions of recombinant α2-adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 1991 ; 30 : 3335-41
69. Lagriffoul A, Charpentier N, Carrette J, Tougard C, Bockaert J, Homburger V. Secretion of protease nexin-1 by C6 glioma cells is under the control of a heterotrimeric G protein, Go1. J Biol Chem 1996 ; 271 : 31508-16
70. Löser C, Fölsh, UR, Paprotny C, Creutzfeld W. Polyamines in human gastric and eosophageal cancer. Scand J Gastroenterol 1989 ; 24 : 1193-9
71. Löw A, Faulhammer HG, Sprinzl M. Affinity labeling of GTP-binding proteins in cellular extracts. FEBS Lett 1992 ; 303 : 64-8
72. Löw A, Sprinzl M, Faulhammer HG. Affinity labeling of c-H-ras p21 consensus elements with periodate-oxidized GDP and GTP. Eur J Biochem 1993 ; 215 : 473-9
73. Marasco WA, Showell HJ, Becker EL. Substance P binds to formylpeptide chemotaxis receptor on the rabbit neutrophil. Biochem Biophys Res Commun 1981 ; 99 : 1065
74. Matsuse T, Thomson RJ., Chen XR, Salari H, Schellenberg RR. Capsaicin inhibits hyperresponsiveness but not lipooxygenase activity or eisinophilia after repeated aerosolized antigen in guinea pigs. Am Rev Respir Dis 1991 ; 144 : 368-72
75. McFerran BW, Guild SB. Effects of mastoparan upon the late stage of the ACTH secretory pathway of AtT-20 cells. Br J Pharmacol 1995 ; 115 : 696-702
76. Miziorko HM, Brodt CA, Krieger TJ. Affinity labeling of spinach leaf phosphoribulokinase by ATP analogs. Modification of an active site lysine. J Biol Chem 1990 ; 265 : 3642-7
77. Mizrahi J, Escher E, Caranikas S, D'Orleans-Juste P, Regoli D. Substance P antagonists active in vitro and in vivo. Eur J Pharmacol 1982 ; 82 : 101-5
78. Mizuno K, Nakahata N, Ohizumi Y. Mastoparan-induced phosphatidylcholine hydrolysis by phospholipase D activation in human astrocytoma cells. Br J Pharmacol 1995 ; 116 : 2090-6
79. Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharmacol Exp Ther 1989 ; 250 : 329-35
80. Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 1990 ; 11 : 358-62
81. Mousli M, Bronner C, Landry Y, Bockaert J, Rouot B. Direct activation of GTP-binding regulatory proteins (G proteins) by substance P and compound 48/80. FEBS Lett 1990 ; 259 : 260-2
82. Mousli M, Bronner C, Bueb JL, Landry Y. Evidence for the interaction of mast cell-degranulating peptide (MCD) with pertussis toxin-sensitive G proteins in mast cells. Eur J Pharmacol 1991 ; 207 : 249-55
83. Mousli M, Hugli TE, Landry Y, Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol 1992 ; 148 : 2456-61
84. Mousli M, Hugli TE, Landry Y, Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cells. Immunopharmacology 1993 ; 1 : 1-11
85. Mousli M, Trifilieff A, Pelton JT, Gies JP, Landry Y. Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur J Pharmacol 1995 ; 289 : 125-33
86. Mukai H, Munekata E, Higashijima T. G protein antagonists. J Biol Chem 1992 ; 267 : 16237-44
87. Münch G, Dees C, Hekman M, Palm D. Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by β-receptor-site-specific synthetic peptides. Eur J Biochem 1991 ; 198 : 357-64
88. Nanoff C, Boehm S, Hohenegger M, Schütz W, Freissmuth M. 2′:3′-dialdehyde GTP as an irreversible G protein antagonist: disruption and reconstitution of G protein-mediated signal transduction in cells and in cell membranes. J Biol Chem 1994, 269 : 31999-2007
89. Neer EJ. G proteins: critical control points for transmembrane signals. Protein Sci 1994 ; 3 : 3-14
90. Neer EJ. Heterotrimeric G proteins : organizers of transmembrane signals. Cell 1995 ; 80 : 249-57
91. Neer EJ. Intracellular signalling: turning down G-protein signals. Curr Biol 1997 ; 7 : R31-3
92. Neill JD, Duck LW, Sellers JC, Musgrove LC, Scheschonka A, Druey KM, Kehrl JH. Potential role for a regulator of G protein signaling (RGS 3) in gonadotropin-releasing hormone (GnRH) stimulated desensitization. Endocrinology 1997 ; 138 : 843-6
93. O'Dowd BF, Hnatowich M, Regan JW, Leader WM, Caron MG, Lefkowitz RJ. Site-directed mutagenesis of the cytoplasmic domains of the human β2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J Biol Chem 1988 ; 263 : 15985-92
94. Okano Y, Takagi H, Tohmatsu T, Saito K, Nozawa Y. A wasp venom mastoparan-induced polyphosphoinositide breakdown in rat peritoneal mast cells. FEBS Lett 1985 ; 188 : 363-6
95. Oppi CT, Wagner T, Crisari A, Camerini B, Valentini GPT. Attenuation of GTPase activity of recombinant Go by peptides representing sequence permutations of mastoparan. Proc Natl Acad Sci USA 1992 ; 89 : 8268-73
96. Ozaki Y, Matsumoto Y, Yatomi Y, Higashihara M, Kariya T, Kume S. Mastoparan, a wasp venom, activates platelets via pertussis toxin-sensitive GTP-binding proteins. Biochem Biophys Res Commun 1990 ; 170 : 779-85
97. Pai EF, Krengl U, Holmes KC, John J, Wittinghofer A. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implication for the mechanism of GTP hydrolysis. EMBO J 1990 ; 9 : 2351-9
98. S protein by site-specific synthetic peptides. FEBS Lett 1989 ; 254 : 89-93
99. Payan DG. Brewster DR, Goetzl EG. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983 ; 131 : 1613-15
100. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982 ; 243 : C212-21
101. Peter ME, Wittmann-Liebold B, Sprinzl M. Affinity labeling of the GDP/GTP binding site in thermus thermophilus elongation factor Tu. Biochemistry 1988 ; 27 : 9132-9
102. Pfisterer MW, Kiowski D, Follath F, Burkart F. Benefecial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol 1992 ; 69 : 1399-402
103. Pincelli C, Fantini F, Massimi P, Girolomoni G, Gianetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990 ; 122 : 745-51
104. Piotrowski W, Devoy MAB, Jordan CC, Foreman JC. The substance P receptor on rat mast cells and in human skin. Agents Actions 1984 ; 14 : 419-24
105. Prichard BNC. β-adrenoceptor blocking agents. In: Abshagen U, eds. Experimental Pharmacology. Berlin: Springer, 1985 ; 385-458
106. Raynor RL, Zherng B, Kuo JF. Membrane interaction of amphiphilic polypeptides mastoparan, melittin, polymyxin B, and cardiotoxin. J Biol Chem 1991 ; 266 : 2753-8
107. Read GW, Kiefer EF. Benzalkonium chloride: a selective inhibitor of histamine release induced by compound 48/80 and other polyamines. J Pharmacol Exp Ther 1979 ; 211 : 711-15
108. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980 ; 32 : 1-46
109. Regoli D, Rhaleb NE, Dion S, Drapeau G. New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends Pharmacol Sci 1990 ; 11 : 156-61
110. Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S. Constitutively active mutants of the α2-adrenergic receptor. J Biol Chem 1993 ; 268 : 16483-7
111. Repke H, Piotrowski W, Bienert M, Foreman JC. Histamine release induced by Arg-Pro-Lys-Pro(CH2)11CH3 from rat peritoneal mast cells. J Pharmacol Ther Exp 1987 ; 243 : 317-21
112. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD. Constitutively active mutants of rhodopsin. Neuron 1992 ; 9 : 719-25
113. Robishaw JD, Russell DW, Harris BA, Gilman AG. Deduced primary structure of the α-subunit of the GTP-binding stimulatory protein of adenylyl cyclase. Proc Natl Acad Sci USA 1986 ; 83 : 1251-5
114. Ross EM. Signal sorting and amplification through G protein-coupled receptors. Neuron 1989 ; 3 : 141-52
115. Ruff MR, Wahl SM, Pert CB. Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985 ; 6 : 107-11
116. Ruvkun G. Cell signaling. a molecular growth industry. Nature 1992 ; 360 : 711-12
117. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the β2-adrenergic receptor : extending the ternary complex model. J Biol Chem 1993 ; 268 : 4625-36
118. Samama P, Gang P, Costa T, Cotecchia S, Lefkowitz RJ. Negative antagonists promote an inactive conformation of the β2-adrenergic receptor. Mol Pharmacol 1993 ; 45 : 390-4
119. Savarese JJ, Covino BG. Basic and clinical pharmacology of local anesthetic drugs. In: Miller MD, eds. Anesthesia. New York: Churchill Livingstone; 1986. p. 985-1013
120. Savarese TM, Fraser CM. In vitro mutagenesis and the search for the structure-function relationships among G protein-coupled receptors. Biochem J 1992 ; 283 : 1-19
121. Schirmer NK, Reiser C, Sprinzl M. Effect of thermus thermophilus elongation factor Ts on the conformation of elongation factor Tu. Eur J Biochem 1991 ; 200 : 295-300
122. Schuber F. Influence of polyamines on membrane functions. Biochem J 1989 ; 260 : 1-10
123. Seifert R, Hagelüken A, Höer A, Höer D, Grünbaum L, Offermanns S, Schultz G. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes. Mol Pharmacol 1994 ; 45 : 578-86
124. Senogles SE, Spiegel AM, Padrell F, Caron MG. Specificity of receptor G protein interactions: discrimination of subtypes by the D2-dopamine receptor in a reconstituted system. J Biol Chem 1990 ; 265 : 4507-14
125. Serra MC, Bazzoni F, Della Biance V, Rossi F. Activation of human neutrophils by substance P. J Immunol 1988 ; 141 : 2118-24
126. Shapiro RA, Nathanson NM. Deletion analysis of the mouse m1 muscarinic acethylcholine receptor: effect of phosphoinositide metabolism and down-regulation. Biochemistry 1989 ; 28 : 8946-50
127. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Culter GB. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993 ; 365 : 652-4
128. Snow BE, Antonio L, Suggs S, Gutstein HB, Siderovski DP. Molecular cloning and expression analysis of rat Rgs12 and Rgs14. Biochem Biophys Res Commun 1997 ; 233 : 770-7
129. Spiegel AM, Weinstein LS, Shenker A. Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest 1993 ; 92 : 1119-25
130. Strader CD, Sigal IS, Dixon RAF. Structural basis of β-adrenergic receptor function. FASEB J 1989 ; 3 : 1825-32
131. Strichartz GR, Ritchie JM. The action of local anesthetics on ion channels of excitable tissues. In: Strichartz GR, eds. Experimental Pharmacology. Berlin: Springer; 1987. p 21-52
132. Sukumar M, Higashijima T. G protein-bound conformation of mastoparan-X, a receptor memitic peptide. J Biol Chem 1992 ; 267 : 21421
133. Summers RJ, McMartin LR, Kompa A, Gu X, Molenaar P. Signalling pathways in cardiac failure. Clin Exp Pharmacol Physiol 1995 ; 22 : 874-6
134. Tabor CW, Tabor H. Polyamines in microorganisms. Microbiol Rev 1985 ; 49 : 81-99
135. Treib K, Dorfinger K, Selzer E, Neuhold N, Wilfing A, Czernin S et al. Suramin affects differentiated and undifferentiated throid epithelial cells in vitro. J Endocrinol 1992 ; 134 : 505-11
136. Van Dop C, Yamanaka G, Steinberg F, Sekura RD, Manclark CR, Stryer L, Bourne HR. ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem 1984 ; 259 : 23-6
137. Varrault A, LeNguyen D, McClue S, Harris B, Jouin P, Bockaert J. 5-Hydroxytryptamine-1A receptor synthetic peptides : mechanisms of adenylyl inhibition. J Biol Chem 1994 ; 269 : 16720-5
138. Vitale N, Mukai H, Rouot B, Thiersé D, Aunis D, Bader MF. Exocytosis in chromaffin cells. J Biol Chem 1993 ; 268 : 14715-19
139. Voss T, Wallner E, Csernilofsky AP, Freissmuth M. An amphipathic α-helical structure does not predict the ability of receptor-derived peptides to interact with G proteins. J Biol Chem 1993 ; 268 : 4637-42
140. Wang JY, Johnson LR. Luminal polyamines stimulate repair of gastric mucosal stress ulcers. Am J Physiol 1990 ; 259 : G584-92
141. Wang ZY, Waldeck K, Grundemar L, Hakanson R. Ocular inflammation induced by electroconvulsive treatments. Br J Pharmacol 1997 ; 120 : 1491-6
142. 2+ current in rat sympathetic neurons. Proc Natl Acad Sci USA 1987 ; 84 : 4313-17
143. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. RGS family members : GTPase activating proteins for heterotrimeric G-protein alpha-subunits. Nature 1996 ; 383 : 172-5
144. Welsh N. A role for polyamines in glucose-stimulated insulin-gene expression. Biochem J 1990 ; 271 : 393-7
145. Williams K. Interactions of polyamines with ion channels. Biochem J 1997 ; 325 : 289-97
146. Yajima Y, Uchino K, Ito H, Kawashima S. Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins. Endocrinology 1997 ; 138 : 1949-58
147. Van Y, Chi PP, Bourne HR. RGS4 inhibits Gq-mediated activation of mitogene-activated protein kinase and phosphoinositide synthesis. J Biol Chem 1997 ; 272 : 11924-7
148. Yokokawa N, Komatsu M, Takeda T, Aizawa T, yamada T. Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein. Biochem Biophys Res Commun 1989 ; 158 : 712-16
149. Zhang L, Mantey S, Jensen RT, Gardner JD. An analog of substance P with broad receptor antagonist activity. Biochim Biophys Acta 1988 ; 972 : 37-42
150. 2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathway. Neuron 1994 ; 13 : 657-69